The weekly litigation news digest is live. Subscribe now

Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma - EP3370729

The patent EP3370729 was granted to Celgene on Sep 27, 2023. The application was originally filed on Nov 4, 2016 under application number EP16810119A. The patent is currently recorded with a legal status of "Revoked".

EP3370729

CELGENE
Application Number
EP16810119A
Filing Date
Nov 4, 2016
Status
Revoked
Nov 8, 2024
Publication Date
Sep 27, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSJun 25, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4868103
DESCRIPTIONUS5539083
DESCRIPTIONUS5631169
DESCRIPTIONUS7442830
DESCRIPTIONUS7687662
DESCRIPTIONUS8003819
DESCRIPTIONUS8530694
DESCRIPTIONWO0105935
DESCRIPTIONWO2009154737
INTERNATIONAL-SEARCH-REPORTWO2012149419
INTERNATIONAL-SEARCH-REPORTWO2015179443
OPPOSITIONWO2012149419

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents